SMB 28112013 Otto Boerman - PRIME Radboudumc

39
Preclinical Imaging Centre Centrum voor preklinische imaging van het Radboud UMC Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Prof. dr. Otto C. Boerman

description

 

Transcript of SMB 28112013 Otto Boerman - PRIME Radboudumc

Page 1: SMB 28112013 Otto Boerman - PRIME Radboudumc

Preclinical Imaging Centre

Centrum voor preklinische imaging van het Radboud UMC

Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Prof. dr. Otto C. Boerman

Page 2: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

RTM: Radboud Translational Medicine

Discovery Screening preclinical testing Clinical trials

Page 3: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

RTM: Radboud Translational Medicine

Discovery Screening preclinical testing Clinical trials

Page 4: SMB 28112013 Otto Boerman - PRIME Radboudumc

Genetics

Bioinformatics Preclinical

pharmacology

Clinical

trials

Flow

cytometry

Cleanrooms

Neuroscience

unit

Robotic

operations

Preclinical

Imaging

Microscopy

Malaria lab Biobank

Big Data

Radboudumc Technology Centres

Proteomics

Metabolomics

Glycomics

Radboudumc

Technology

Centers

Alain van Gool Otto Boerman

Page 5: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

PRIME: Preclinical Imaging Centre

microSPECT

Page 6: SMB 28112013 Otto Boerman - PRIME Radboudumc

From human imaging to small animal imaging

Page 7: SMB 28112013 Otto Boerman - PRIME Radboudumc

Dopamine w/ 99mTc-TRODAT Neurology

Uptake of 123I-IBF by D2 receptors

Stress 99mTc-MIBI Cardiovascular

99mTc-MIBI

Renal Cell Carcinoma Oncology

[99mTc] Minigastrin

Mouse Human

*functional imaging

From human imaging to small animal imaging

Page 8: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

Page 9: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

Page 10: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

Page 11: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

Page 12: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

Page 13: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

PRIME

Preclinical Imaging Centre

PET imaging in PRIME

microSPECT

Page 14: SMB 28112013 Otto Boerman - PRIME Radboudumc

Annihilation

Radboud University Nijmegen Medical Centre, The Netherlands

Page 15: SMB 28112013 Otto Boerman - PRIME Radboudumc

FDG-PET: imaging cancer

Normal FDG-PET Metastasized Melanoma

Page 16: SMB 28112013 Otto Boerman - PRIME Radboudumc

FDG-PET: functional imaging

Monitor response to treatment

Dept. Nuclear Medicine, Radboud University Nijmegen Medical Centre

Pre treatment

4 weeks after

start of treatment

24 weeks after

start of treatment

Pre treatment

Page 17: SMB 28112013 Otto Boerman - PRIME Radboudumc

FDG-PET: functional imaging

Monitor response to treatment

Dept. Nuclear Medicine, Radboud University Nijmegen Medical Centre

Pre treatment

4 weeks after

start of treatment

24 weeks after

start of treatment

Pre treatment 1 week after start of

imatinib treatment

Page 18: SMB 28112013 Otto Boerman - PRIME Radboudumc

Dept. Nuclear Medicine, Radboud University Nijmegen Medical Centre

Pre treatment

4 weeks after

start of treatment

24 weeks after

start of treatment

FDG-PET: functional imaging

Monitor response to treatment

Pre treatment 1 week after start of

imatinib treatment

Page 19: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

microPET/CT scanner

Page 20: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Center, The Netherlands

- 1 day

Monitor the therapeutic effect of a new anti-cancer drug

Page 21: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Center, The Netherlands

- 1 day 1 day

Monitor the therapeutic effect of a new anti-cancer drug

Page 22: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Center, The Netherlands

- 1 day 1 day 3 days

Monitor the therapeutic effect of a new anti-cancer drug

Page 23: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Center, The Netherlands

- 1 day 1 day 3 days 7 days

Monitor the therapeutic effect of a new anti-cancer drug

Page 24: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

PRIME

Preclinical Imaging Centre

SPECT imaging in PRIME

microSPECT

Page 25: SMB 28112013 Otto Boerman - PRIME Radboudumc

Small animal SPECT imaging

Radboud University Nijmegen Medical Centre, The Netherlands

Page 26: SMB 28112013 Otto Boerman - PRIME Radboudumc

26

Radboud University Nijmegen Medical Centre, The Netherlands

Page 27: SMB 28112013 Otto Boerman - PRIME Radboudumc

microSPECT imaging

Radboud University Nijmegen Medical Centre, The Netherlands

Page 28: SMB 28112013 Otto Boerman - PRIME Radboudumc

Diabetes type 1: autoimmune destruction of insulin producing beta cells

Islet transplantation is a promising treatment for patients with type1 diabetes

AIM: Non-invasive in vivo determination of beta cell mass after islet transplantation.

islets

In-111-DTPA-Exendin

Imaging transplated islets of Langerhans

Radboud University Nijmegen Medical Centre, The Netherlands

Page 29: SMB 28112013 Otto Boerman - PRIME Radboudumc

Imaging transplated islets of Langerhans

Radboud University Nijmegen Medical Centre, The Netherlands

Page 30: SMB 28112013 Otto Boerman - PRIME Radboudumc

2D

3W

11W

Imaging transplated islets of Langerhans

6W

8W

In-111-Exendin

Radboud University Nijmegen Medical Centre, The Netherlands

Page 31: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

PRIME

Preclinical Imaging Centre

Intravital fluorescence imaging in PRIME

microSPECT

Page 32: SMB 28112013 Otto Boerman - PRIME Radboudumc

Multi-photon fluorescence microscopy

Radboud University Nijmegen Medical Centre, The Netherlands

Page 33: SMB 28112013 Otto Boerman - PRIME Radboudumc

Monitoring of tumor development using the dorsal skinfold chamber model

Multi-photon fluorescence microscopy

Radboud University Nijmegen Medical Centre, The Netherlands

Page 34: SMB 28112013 Otto Boerman - PRIME Radboudumc

Tumor cells

Extracellular

matrix, collagen,

muscle fibers

Fat cells, nerves

Blood vessels,

immune cells

Multi-photon fluorescence microscopy

Radboud University Nijmegen Medical Centre, The Netherlands

Page 35: SMB 28112013 Otto Boerman - PRIME Radboudumc

Tumor cells

Extracellular matrix,

collagen, muscle fibers

Fat cells, nerves

Blood vessels, immune

cells

Multi-photon fluorescence microscopy

Radboud University Nijmegen Medical Centre, The Netherlands

Page 36: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Center, The Netherlands

Immunofluorescence Guided Surgery

Page 37: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Center, The Netherlands

Immunofluorescence Guided Surgery

Page 38: SMB 28112013 Otto Boerman - PRIME Radboudumc

Multi-modality Imaging

Radboud University Nijmegen Medical Centre, The Netherlands

Fluorescence imaging

MRI

PET

Multiphoton imaging

Page 39: SMB 28112013 Otto Boerman - PRIME Radboudumc

Radboud University Nijmegen Medical Centre, The Netherlands

Drug development Research

Hoffmann La Roche

Novartis

Sanofi

Fuji Biotechnology

Future Chemistry

Immunomedics Inc.

Synaffix

Wilex

Milabs